Skip to content

Cerys Clayden

2 papers in the library · 2 citations · publishing 2025-2026

Papers

Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context.

Journal of psychoactive drugs July 2, 2025 Grace Stockwell, Nicholas R Hoeh, Francesca Fogarty et al. 2 citations

In-depth interviews with 12 people receiving ketamine-assisted therapy for treatment-resistant depression reveal that preparation of mind-set—including openness, clear intentions, mindfulness, and understanding how the therapy works—supports therapeutic benefit. Comfort in the setting, fostered by learning about the therapist's personal experiences, a strong therapeutic alliance, and feeling safe, helps patients 'let go.' External cues like music can guide a spiritual journey. Caution is warranted when trauma surfaces and letting go leaves patients feeling vulnerable. These contextual processes inform future clinical trials and improve the efficacy of ketamine-assisted therapy.

It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial

Palliative & Supportive Care January 1, 2026 Fiona Cottam, Alesha Wells, Cerys Clayden et al.

Participating in trials of psychedelic-assisted meaning-centered psychotherapy (MCP) may provide hope for both cancer patients and their caregivers. Because the well-being of patients and caregivers is interconnected, the authors argue that caregivers should be included alongside patients in these clinical trials.